Chief medical officer, Gilead Sciences
Appears in 1 story
Spokesperson for the drug's regulatory milestones
Roughly 5% of Americans living with HIV take their antiretrovirals as several pills a day, because resistance, side effects, or other medications rule out standard single tablets. On Thursday the FDA approved a pill built for that group.
Updated Yesterday
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
